Alumis Inc. Common Stock
Symbol: ALMS (NASDAQ)
3.87
▲ (0.26%) 0.010
Company Description:
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.
Key Stats
- Today's Open: $4.12
- Today's High: $4.14
- Today's Low: $3.855
- Today's Volume: 660.81K
- Yesterday Close: $3.86
- Yesterday High: $4.16
- Yesterday Low: $3.77
- Yesterday Volume: 1.05M
- Last Min Volume: 10
- Last Min High: $3.87
- Last Min Low: $3.87
- Last Min VWAP: $3.87
Company Profile
- Name: Alumis Inc. Common Stock
- Website: https://www.alumis.com
- Listed Date: 2024-06-28
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001847367
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $398.31M
- Round Lot: 100
- Outstanding Shares: 103.19M
- Asset Type: CS
RECENT FILINGS FOR ALMS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-14 | 4 | View |
| 2025-07-14 | 3 | View |
| 2025-07-03 | S-3 | View |
| 2025-06-30 | 8-K/A | View |
| 2025-06-16 | ARS | View |
| 2025-06-16 | DEFA14A | View |
| 2025-06-16 | DEF 14A | View |
| 2025-06-10 | S-8 | View |
| 2025-06-10 | SCHEDULE 13D/A | View |
| 2025-05-23 | SCHEDULE 13D/A | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | SCHEDULE 13D/A | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 3 | View |
| 2025-05-21 | 8-K | View |
| 2025-05-19 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-14 | 8-K | View |
| 2025-05-07 | SCHEDULE 13D/A | View |
Latest News on ALMS